Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant |
|---|---|
| Disease/Condition | Obstetrics & Gynecology and Women`s Health,Urologic Oncology (Med Onc),Cancer,Carcinoma,Urogenital Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Nicole Nevadunsky, MD |
| Contact Name | Meghan Proehl |
| Contact Email | mproehl@montefiore.org |
| Protocol Number | 2018-9873 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Cancer-Related Ovary |
| Adult, Pediatric, Both | Adult |
